Agfa lands huge Australian PACS deal
PACS firm Agfa has received a $25 million contract from Queensland Health of Australia, which will use the Ridgefield Park, NJ-based firm’s Impax PACS offering to link the imaging units at five tertiary teaching hospitals. Impax software,
PACS firm Agfa has received a $25 million contract from Queensland Health of Australia, which will use the Ridgefield Park, NJ-based firms Impax PACS offering to link the imaging units at five tertiary teaching hospitals. Impax software, workstations, and other hardware for electronic image capture, transmission, display, and archiving will be provided to the Royal Brisbane, Royal Womens, Royal Childrens, Princess Alexandra, and Townsville General hospitals. Agfa will also serve as a systems integrator, linking Impax with four other major digital technology suppliers. Queensland Health hopes to convert to a totally filmless environment within two to three years, according to Agfa.
ASCO: Study Reveals Significant Racial/Ethnic Disparities with PSMA PET Use for Patients with mPCa
May 30th 2025Latinx patients with metastatic prostate cancer were 63 percent less likely than non-Hispanic White patients to have PSMA PET scans, according to a study of 550 patients presented at the American Society of Clinical Oncology (ASCO) conference.
Lunit Unveils Enhanced AI-Powered CXR Software Update
May 28th 2025The Lunit Insight CXR4 update reportedly offers new features such as current-prior comparison of chest X-rays (CXRs), acute bone fracture detection and a 99.5 percent negative predictive value (NPV) for identifying normal CXRs.
New MRI Study Questions Use of Corticosteroid Injections for Knee OA
May 27th 2025Two years after intraarticular knee injections for knee osteoarthritis (OA), study participants who had corticosteroid knee injections had greater OA progression than control patients while the use of hyaluronic acid injections was associated with less OA progression.
